CIK: 0002088557
申報總市值
US$7.1億
申報季度: 2026-03-31 · 持股檔數: 31
Defilade Capital Management, L.P.在最新一期 13F 報告中揭露了 31 項持股，申報期為 2026-03-31，總持股市值約為 US$7.1億，季度換手率為 98.7%。
Defilade Capital Management, L.P. 目前揭露的持股，Herfindahl 集中度指數為 0.041——換算下來相當於約 24 個等權重部位，與其實際揭露的 31 檔持股相當接近。資金分佈相對平均，並未集中於少數標的。
整體部位大小相當一致（變異係數為 0.54），顯示該機構在資金配置上採取較有紀律、規則化的方式。
最新申報季度中，並未觀察到明顯偏向加碼既有大部位或大舉建立新部位的傾向。
目前產業板塊分類約涵蓋此投資組合揭露價值的 70%；其餘部分（例如未對應板塊的標的、選擇權或其他證券類型）尚未納入板塊分類範圍。
減碼 PFE
-33.6% -US$3546.1萬
加碼 BDX
+243.8% US$2814.0萬
加碼 INSM
+289.8% US$2317.0萬
加碼 HSIC
+94.8% US$2177.4萬
加碼 DXCM
+120.0% US$1758.2萬
減碼 PACS
-47.3% -US$1834.7萬
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ZBH | Zimmer Biomet Holdings INC | 股票-醫療保健 | 7.35% | +7.35% | NEW | |
| 2 | HSIC | Henry Schein INC | 股票-醫療保健 | 6.46% | +3.18% | +94.75% | |
| 3 | BDX | Becton Dickinson And Co | 股票-醫療保健 | 6.16% | +4.02% | +243.82% | |
| 4 | PTCT | Ptc Therapeutics INC | 股票-醫療保健 | 5.77% | +5.77% | NEW | |
| 5 | DXCM | Dexcom INC | 股票-醫療保健 | 4.75% | +2.55% | +120.01% | |
| 6 | ICUI | Icu Medical INC | 股票-其他 | 4.61% | -1.98% | -25.37% | |
| 7 | INSM | Insmed INC | 股票-醫療保健 | 4.48% | +3.30% | +289.82% | |
| 8 | ISRG | Intuitive Surgical INC | 股票-醫療保健 | 4.38% | +0.87% | +48.22% | |
| 9 | RVMD | Revolution Medicines INC | 股票-醫療保健 | 4.31% | +0.39% | -13.06% | |
| 10 | GMED | Globus Medical INC - A | 股票-醫療保健 | 4.29% | +1.13% | +32.61% | |
| 11 | NBIX | Neurocrine Biosciences INC | 股票-醫療保健 | 3.88% | +3.88% | NEW | |
| 12 | DNLI | Denali Therapeutics INC | 股票-其他 | 3.67% | +2.20% | +107.09% | |
| 13 | PACS | Pacs Group INC | 股票-其他 | 3.60% | -2.36% | -47.26% | |
| 14 | OLMA | Olema Pharmaceuticals INC | 股票-其他 | 3.15% | -1.03% | +21.86% | |
| 15 | ELAN | Elanco Animal Health INC | 股票-醫療保健 | 3.13% | +1.90% | +132.04% | |
| 16 | PFE | Pfizer INC | 股票-醫療保健 | 2.72% | -4.72% | -33.55% | |
| 17 | LLY | Eli Lilly & Co | 股票-醫療保健 | 2.67% | -1.98% | -35.22% | |
| 18 | LNTH | Lantheus Holdings INC | 股票-醫療保健 | 2.66% | +2.66% | NEW | |
| 19 | ITGR | Integer Holdings CORP | 股票-醫療保健 | 2.63% | +2.63% | NEW | |
| 20 | BIIB | Biogen INC | 股票-醫療保健 | 2.48% | -1.38% | -40.56% | |
| 21 | EVMN | Evommune INC | 股票-其他 | 2.19% | +1.69% | +215.01% | |
| 22 | TNDM | Tandem Diabetes Care INC | 股票-其他 | 2.05% | +2.05% | NEW | |
| 23 | COGT | Cogent Biosciences INC | 股票-其他 | 1.91% | -0.83% | -37.99% | |
| 24 | NUVL | Nuvalent Inc-a | 股票-其他 | 1.87% | -1.80% | -51.70% | |
| 25 | OCUL | Ocular Therapeutix INC | 股票-其他 | 1.77% | +0.65% | +118.24% | |
| 26 | ASND | Ascendis Pharma A/S | 股票-其他 | 1.67% | -0.81% | -39.44% | |
| 27 | ALGN | Align Technology INC | 股票-醫療保健 | 1.62% | -1.09% | -47.42% | |
| 28 | ELDN | Eledon Pharmaceuticals INC | 股票-其他 | 1.54% | +0.87% | +8.32% | |
| 29 | ORIC | Oric Pharmaceuticals INC | 股票-其他 | 1.50% | +1.50% | NEW | |
| 30 | BHVN | Biohaven Ltd. | 股票-其他 | 0.38% | +0.38% | NEW | |
| 31 | MREO | Mereo Biopharma Group Pl-adr | 股票-其他 | 0.35% | +0.35% | NEW |
Q3 2026績效
+6.6%
近4個季度績效
+3%
根據可用的5個月歷史資料
根據可取得價格的持股（佔申報價值的67%）計算
Defilade Capital Management, L.P. 在 2026-03-31 最顯著的持倉異動： 新建倉: Zimmer Biomet Holdings INC (ZBH); 清倉: Abbvie INC (ABBV); 清倉: Novartis Ag-sponsored Adr (NVS); 新建倉: Ptc Therapeutics INC (PTCT); 清倉: STERIS plc (STE).
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | BDX | Becton Dickinson And Co | +4% | +243.82% | 加碼 |
| 2 | INSM | Insmed INC | +3.3% | +289.82% | 加碼 |
| 3 | HSIC | Henry Schein INC | +3.2% | +94.75% | 加碼 |
| 4 | DXCM | Dexcom INC | +2.6% | +120.01% | 加碼 |
| 5 | DNLI | Denali Therapeutics INC | +2.2% | +107.09% | 加碼 |
| 6 | ELAN | Elanco Animal Health INC | +1.9% | +132.04% | 加碼 |
| 7 | EVMN | Evommune INC | +1.7% | +215.01% | 加碼 |
| 8 | GMED | Globus Medical INC - A | +1.1% | +32.61% | 加碼 |
| 9 | ELDN | Eledon Pharmaceuticals INC | +0.9% | +8.32% | 加碼 |
| 10 | ISRG | Intuitive Surgical INC | +0.9% | +48.22% | 加碼 |
| 11 | OCUL | Ocular Therapeutix INC | +0.7% | +118.24% | 加碼 |
| 12 | RVMD | Revolution Medicines INC | +0.4% | -13.06% | 減碼 |
| 13 | ASND | Ascendis Pharma A/S | -0.8% | -39.44% | 減碼 |
| 14 | COGT | Cogent Biosciences INC | -0.8% | -37.99% | 減碼 |
| 15 | OLMA | Olema Pharmaceuticals INC | -1% | +21.86% | 加碼 |
| 16 | ALGN | Align Technology INC | -1.1% | -47.42% | 減碼 |
| 17 | BIIB | Biogen INC | -1.4% | -40.56% | 減碼 |
| 18 | NUVL | Nuvalent Inc-a | -1.8% | -51.70% | 減碼 |
| 19 | ICUI | Icu Medical INC | -2% | -25.37% | 減碼 |
| 20 | LLY | Eli Lilly & Co | -2% | -35.22% | 減碼 |
| 21 | PACS | Pacs Group INC | -2.4% | -47.26% | 減碼 |
| 22 | PFE | Pfizer INC | -4.7% | -33.55% | 減碼 |
| 23 | ZBH | Zimmer Biomet Holdings INC | — | NEW | 新建倉 |
| 24 | ABBV | Abbvie INC | — | EXIT | 清倉 |
| 25 | NVS | Novartis Ag-sponsored Adr | — | EXIT | 清倉 |
| 26 | PTCT | Ptc Therapeutics INC | — | NEW | 新建倉 |
| 27 | STE | STERIS plc | — | EXIT | 清倉 |
| 28 | NBIX | Neurocrine Biosciences INC | — | NEW | 新建倉 |
| 29 | XNCR | Xencor INC | — | EXIT | 清倉 |
| 30 | LNTH | Lantheus Holdings INC | — | NEW | 新建倉 |
| 31 | ITGR | Integer Holdings CORP | — | NEW | 新建倉 |
| 32 | ATRC | Atricure INC | — | EXIT | 清倉 |
| 33 | LIVN | LivaNova PLC | — | EXIT | 清倉 |
| 34 | TNDM | Tandem Diabetes Care INC | — | NEW | 新建倉 |
| 35 | ATEC | Alphatec Holdings INC | — | EXIT | 清倉 |
| 36 | ORIC | Oric Pharmaceuticals INC | — | NEW | 新建倉 |
| 37 | GKOS | Glaukos CORP | — | EXIT | 清倉 |
| 38 | RXST | Rxsight INC | — | EXIT | 清倉 |
| 39 | TFX | Teleflex INC | — | EXIT | 清倉 |
| 40 | CNMD | Conmed CORP | — | EXIT | 清倉 |
| 41 | BHVN | Biohaven Ltd. | — | NEW | 新建倉 |
| 42 | MREO | Mereo Biopharma Group Pl-adr | — | NEW | 新建倉 |
| 季度 | 申報日期 | 類型 | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025-12-31 | 2026-02-13 | 13F-HR | 在 EDGAR 上查看 |
資產規模相近的機構
CIK 0002109121
申報總市值
US$7.1億
177 stks
2026-03-31
資產規模與本機構相差僅 0.0%
CIK 0001803291
申報總市值
US$7.1億
110 stks
2026-03-31
資產規模與本機構相差僅 0.0%
CIK 0001677501
申報總市值
US$7.1億
520 stks
2026-03-31
資產規模與本機構相差僅 0.0%
持倉風格相似的機構
CIK 0000884535
申報總市值
US$7.3億
67 stks
2019-03-31
資料過舊，未更新
前五大持倉重疊 1/5 檔，同樣重倉 Dexcom INC
CIK 0000896159
申報總市值
US$2989.8萬
3 stks
2022-12-31
資料過舊，未更新
前五大持倉重疊 1/5 檔，同樣重倉 Ptc Therapeutics INC
CIK 0000922940
申報總市值
US$13.2億
36 stks
2026-03-31
前五大持倉重疊 1/5 檔，同樣重倉 Henry Schein INC